Drug Trial Radar · NCT00658788
Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis
Last checked: Nov 19, 2026Latest source record: Aug 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
305
Actual
Start
Mar 2008
Primary completion
Jan 2009
Study completion Jan 2009
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Apr 15, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objectives of this study are to evaluate the safety \& efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.
Conditions
- Psoriasis
Interventions
clobetasol propionate spray 0.05%Drug
clobetasol propionate spray, 0.05%, applied topically twice daily
calcitriol ointmentDrug
calcitriol ointment, 3 µg/g, applied topically, not to exceed 30 g daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Disease Severity Success (ODS)Time frame: 8 and 12 weeks
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Therapeutics Clinical Research
San Diego, California
MedaPhase, Inc.
Newnan, Georgia
Gwinnett Clinical Research Center, Inc
Snellville, Georgia
Hudson Dermatology
Evansville, Indiana
Mount Sinai Department of Dermatology
New York, New York
Northeastern Ohio Universities College of Medicine
Warren, Ohio
Central Sooner Research
Norman, Oklahoma
J&J Studies, Inc
College Station, Texas
Suzanne Bruce and Associates, PA
Houston, Texas
Virginia Clinical Research, Inc
Norfolk, Virginia
Dermatology Associates of Seattle, PLLC
Seattle, Washington
Madison Skin and Research, Inc
Madison, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.